ProCE Banner Activity

New Developments in HR-Positive/HER2-Negative Breast Cancer: Insights From SABCS 2019

Clinical Thought
Get insights from Joyce O’Shaughnessy, MD, on key studies in HR-positive/HER2-negative breast cancer presented at the 2019 Breast Cancer meeting in San Antonio.

Released: January 31, 2020

Expiration: January 29, 2021

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Genentech TEXT Only

Merck Sharp & Dohme Corp.

Puma Biotechnology, Inc.

Seagen